Literature DB >> 7051337

Recent advances in malaria with special reference to Southeast Asia.

T Harinasuta, K E Dixon, D A Warrell, E B Doberstyn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7051337

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN： 0125-1562            Impact factor:   0.267


× No keyword cloud information.
  10 in total

1.  A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.

Authors:  J M de Souza; U K Sheth; R M de Oliveira; A T Gomes; E Q Cavalcante
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

2.  Factors contributing to the development of cerebral malaria. II. Endotoxin.

Authors:  W Usawattanakul; S Tharavanij; D A Warrell; S Looareesuwan; N J White; S Supavej; S Soikratoke
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

3.  Malaria on the Thai-Burmese border: treatment of 5192 patients with mefloquine-sulfadoxine-pyrimethamine.

Authors:  F Nosten; S Imvithaya; M Vincenti; G Delmas; G Lebihan; B Hausler; N White
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

4.  An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil.

Authors:  J M de Souza; U K Sheth; R M de Oliveira; H Roulet; S D de Souza
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

5.  In vitro susceptibility of Plasmodium falciparum collected from pyrimethamine-sulfadoxine sensitive and resistant areas in Thailand.

Authors:  A Sabchareon; T Chongsuphajaisiddhi; P Attanath; K Kanjanapipatkul; E B Doberstyn; L Suebsaeng
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

6.  Plasma and whole blood mefloquine concentrations during treatment of chloroquine-resistant falciparum malaria with the combination mefloquine-sulphadoxine-pyrimethamine.

Authors:  J Karbwang; S Looareesuwan; R E Phillips; Y Wattanagoon; M E Molyneux; B Nagachinta; D J Back; D A Warrell
Journal:  Br J Clin Pharmacol       Date:  1987-04       Impact factor: 4.335

7.  A phase II clinical trial of mefloquine in Brazilian male subjects.

Authors:  J M de Souza
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

8.  Plasmodium falciparum: inhibition/reversal of cytoadherence of Thai isolates to melanoma cells by local immune sera.

Authors:  B Singh; M Ho; S Looareesuwan; E Mathai; D A Warrell; M Hommel
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

9.  The pharmacokinetics of mefloquine when given alone or in combination with sulphadoxine and pyrimethamine in Thai male and female subjects.

Authors:  J Karbwang; D Bunnag; A M Breckenridge; D J Back
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

10.  A phase II clinical trial of mefloquine in patients with chloroquine-resistant falciparum malaria in Thailand.

Authors:  T Harinasuta; D Bunnag; W H Wernsdorfer
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.